These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26233772)

  • 1. Epicardial Adipose Tissue and No-Reflow Phenomenon: Adipokines as Regulators of Coronary Microcirculation?
    Antonopoulos AS; Antoniades C; Tousoulis D
    Hellenic J Cardiol; 2015; 56(4):320-3. PubMed ID: 26233772
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive Value of the No-Reflow Phenomenon and Epicardial Adipose Tissue for Clinical Outcomes After Primary Percutaneous Coronary Intervention.
    Zencirci AE; Zencirci E; Değirmencioğlu A; Erdem A; Karakuş G; Özden K; Karadeniz F; Buturak A; Belen E; Tipi F; Eren M
    Hellenic J Cardiol; 2015; 56(4):311-9. PubMed ID: 26233771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial no-reflow phenomenon: recent knowledges].
    Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
    Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The no-reflow phenomenon.
    Galiuto L; Rebuzzi AG; Crea F
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):85-6. PubMed ID: 19356539
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment.
    Wong DT; Puri R; Richardson JD; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Sep; 167(5):1798-806. PubMed ID: 23357047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting coronary no-reflow in patients with acute myocardial infarction.
    Jaffe R
    Cardiology; 2013; 124(3):151-2. PubMed ID: 23467033
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting the no-reflow phenomenon following successful percutaneous coronary intervention.
    Galiuto L; Paraggio L; Liuzzo G; de Caterina AR; Crea F
    Biomark Med; 2010 Jun; 4(3):403-20. PubMed ID: 20550474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [No reflow phenomenon in acute myocardial infarction].
    Ito H
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():142-6. PubMed ID: 22518981
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction].
    Wang ZY; Liu N; Lei LC; Ren LH; Ye HM; Peng JJ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3403-6. PubMed ID: 23327699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of MACE in MI: what's the MO?
    Reichek N
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):953-5. PubMed ID: 25212801
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Muscle Strength and Increased Visceral Fat Associated With No-reflow and High Gensini Score in STEMI.
    Ayça B; Kafadar D; Avsar M; Avci Iİ; Akın F; Okuyan E; Dinckal MH
    Clin Appl Thromb Hemost; 2017 May; 23(4):367-373. PubMed ID: 26494853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
    Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2009 Aug; 54(1):36-44. PubMed ID: 19632518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.